Crossmark

Population pharmacokinetics and pharmacodynamics of a novel vascular adhesion protein-1 inhibitor using a multiple-target mediated drug disposition model

Crossref DOI link: https://doi.org/10.1007/s10928-020-09717-w

Published Online: 2020-09-15

Published Print: 2021-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Snelder, Nelleke https://orcid.org/0000-0003-1302-678X
Hoefman, Sven

Garcia-Hernandez, Alberto

Onkels, Hartmut

Larsson, Tobias E.

Bergmann, Kirsten R.
Funding

Funding for this research was provided by:

Astellas Pharma, Inc.
License Information

Text and Data Mining valid from 2020-09-15

Version of Record valid from 2020-09-15
More Information

Article History

Received: 20 November 2019

Accepted: 1 September 2020

First Online: 15 September 2020

Compliance with ethical standards

:

: Nelleke Snelder and Sven Hoefman are consultants at LAP&P. Alberto Garcia-Hernandez, Hartmut Onkels, Tobias E. Larsson, Kirsten R. Bergmann are former employees of Astellas.

Document is current

Any future updates will be listed below